U.S. markets closed

iRhythm Technologies, Inc. (IRTC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
105.60+3.84 (+3.77%)
At close: 04:00PM EST
105.86 +0.26 (+0.25%)
After hours: 07:06PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Continuation Wedge (Bullish)

Continuation Wedge (Bullish)

Previous Close101.76
Bid105.62 x 800
Ask105.96 x 1200
Day's Range100.42 - 106.50
52 Week Range41.66 - 286.19
Avg. Volume550,929
Market Cap3.107B
Beta (5Y Monthly)1.31
PE Ratio (TTM)N/A
EPS (TTM)-2.69
Earnings DateFeb 23, 2022 - Feb 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est114.80
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for IRTC

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • iRhythm Technologies, Inc.
    Analyst Report: Medtronic plcOne of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
    Fair Value
    Economic Moat
    4 days agoMorningstar
View more
  • Zacks

    IRhythm Technologies (IRTC) Reports Q3 Loss, Tops Revenue Estimates

    iRhythm Technologies (IRTC) delivered earnings and revenue surprises of 25.69% and 2.27%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    iRhythm Technologies Announces Third Quarter 2021 Financial Results

    SAN FRANCISCO, Nov. 04, 2021 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended September 30, 2021. Third Quarter 2021 Financial Highlights Revenue was $85.4 million, a 18.7% increase compared to third quarter 2020Gross margin was 65.7%, a 8.9% decrease compared to third quarter 2020Adjusted EBITDA (defined as EBITDA less stock compen

  • Motley Fool

    Why iRhythm Technologies Stock Skyrocketed Today

    Shares of iRhythm Technologies (NASDAQ: IRTC) skyrocketed by 59% in Wednesday trading after the Centers for Medicare and Medicaid Services (CMS) released its Calendar Year 2022 Medicare Physician Fee Schedule (MPFS) Final Rule on Tuesday. The MPFS details the payment policies and rates for services provided to Medicare beneficiaries.